Other Species / Isoforms
  CREB3L2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S72-p
EVEPSPTsPAPLIQA
0 1
CREB3L2 (human) EVEPSPTsPAPLIQA S72-p
CREB3L2 (mouse) EVEPSPTSPAPLIQA S72
CREB3L2 (rat) EVEPSPTSPAPLIQA S72
S93-p
CEEPRAQsPFTHITT
0 2
CREB3L2 (human) CEEPRAQsPFTHITT S93-p
CREB3L2 (mouse) SEEPRTQsPFTHAAT S93-p
CREB3L2 (rat) SEEPRAQSPFTHVAA S93
K176-ub
SCQTIIPkIkLEPHE
0 1
CREB3L2 (human) SCQTIIPkIkLEPHE K176-ub
CREB3L2 (mouse) SCQTLIPKIKLEPHE K176
CREB3L2 (rat) SCQTLIPKIKLEPHE K176
K178-ub
QTIIPkIkLEPHEVD
0 2
CREB3L2 (human) QTIIPkIkLEPHEVD K178-ub
CREB3L2 (mouse) QTLIPKIKLEPHEVD K178
CREB3L2 (rat) QTLIPKIKLEPHEVD K178
K178-sm
QTIIPkIkLEPHEVD
0 1
CREB3L2 (human) QTIIPkIkLEPHEVD K178-sm
CREB3L2 (mouse) QTLIPKIKLEPHEVD K178
CREB3L2 (rat) QTLIPKIKLEPHEVD K178
S191-p
VDQFLNFsPKEAPVD
Upstream
0 11
Treatment
  • rapamycin
CREB3L2 (human) VDQFLNFsPKEAPVD S191-p
CREB3L2 (mouse) VDQFLNFsPKEASVD S191-p
CREB3L2 (rat) VDQFLNFSPKEASVD S191
S228-p
NPRLHPFsLPQtHsP
0 1
CREB3L2 (human) NPRLHPFsLPQtHsP S228-p
CREB3L2 (mouse) NPRLHPFSLSQAHsP S228
CREB3L2 (rat) NPRLHPFSLSQAHSP S228
T232-p
HPFsLPQtHsPSRAA
0 2
CREB3L2 (human) HPFsLPQtHsPSRAA T232-p
CREB3L2 (mouse) HPFSLSQAHsPARAM A232
CREB3L2 (rat) HPFSLSQAHSPGRAM A232
S234-p
FsLPQtHsPSRAAPR
0 6
CREB3L2 (human) FsLPQtHsPSRAAPR S234-p
CREB3L2 (mouse) FSLSQAHsPARAMPR S234-p
CREB3L2 (rat) FSLSQAHSPGRAMPR S234
S244-p
RAAPRAPsALSSsPL
0 1
CREB3L2 (human) RAAPRAPsALSSsPL S244-p
CREB3L2 (mouse) RAMPRGPSALSTSPL S244
CREB3L2 (rat) RAMPRGPSALSTSPL S244
S249-p
APsALSSsPLLTAPH
0 2
CREB3L2 (human) APsALSSsPLLTAPH S249-p
CREB3L2 (mouse) GPSALSTSPLLTAPH S249
CREB3L2 (rat) GPSALSTSPLLTAPH S249
K257-ub
PLLTAPHkLQGsGPL
0 1
CREB3L2 (human) PLLTAPHkLQGsGPL K257-ub
CREB3L2 (mouse) PLLTAPHKLQGSGPL K257
CREB3L2 (rat) PLLTAPHKLQGSGPL K257
S261-p
APHkLQGsGPLVLtE
0 1
CREB3L2 (human) APHkLQGsGPLVLtE S261-p
CREB3L2 (mouse) APHKLQGSGPLVLTE S261
CREB3L2 (rat) APHKLQGSGPLVLTE S261
T267-p
GsGPLVLtEEEkRTL
0 1
CREB3L2 (human) GsGPLVLtEEEkRTL T267-p
CREB3L2 (mouse) GSGPLVLTEEEKRTL T267
CREB3L2 (rat) GSGPLVLTEEEKRTL T267
K271-ub
LVLtEEEkRTLIAEG
0 1
CREB3L2 (human) LVLtEEEkRTLIAEG K271-ub
CREB3L2 (mouse) LVLTEEEKRTLVAEG K271
CREB3L2 (rat) LVLTEEEKRTLIAEG K271
K289-ub
PTKLPLSksEEKALK
0 1
CREB3L2 (human) PTKLPLSksEEKALK K289-ub
CREB3L2 (mouse) PTKLPLTKSEEKALK K289
CREB3L2 (rat) PTKLPLTKSEEKALK K289
S290-p
TKLPLSksEEKALKK
0 1
CREB3L2 (human) TKLPLSksEEKALKK S290-p
CREB3L2 (mouse) TKLPLTKSEEKALKK S290
CREB3L2 (rat) TKLPLTKSEEKALKK S290
K325-ub
YMDSLEKkVESCSTE
0 1
CREB3L2 (human) YMDSLEKkVESCSTE K325-ub
CREB3L2 (mouse) YMDSLEKKVESCSTE K325
CREB3L2 (rat) YMDSLEKKVESCSTE K325
K325-sm
YMDSLEKkVESCSTE
0 1
CREB3L2 (human) YMDSLEKkVESCSTE K325-sm
CREB3L2 (mouse) YMDSLEKKVESCSTE K325
CREB3L2 (rat) YMDSLEKKVESCSTE K325
K339
ENLELRKKVEVLENT
0 1
CREB3L2 (human) ENLELRKKVEVLENT K339
CREB3L2 (mouse) ENLELRKkVEVLENT K339-ac
CREB3L2 (rat) ENLELRKKVEVLENT K339
K339-ub
ENLELRKkVEVLENT
0 1
CREB3L2 (human) ENLELRKkVEVLENT K339-ub
CREB3L2 (mouse) ENLELRKKVEVLENT K339
CREB3L2 (rat) ENLELRKKVEVLENT K339
K356-ub
TLLQQLQkLQTLVMG
0 5
CREB3L2 (human) TLLQQLQkLQTLVMG K356-ub
CREB3L2 (mouse) TLLQQLQkLQTLVMG K356-ub
CREB3L2 (rat) TLLQQLQKLQTLVMG K356
K364-ub
LQTLVMGkVSRtCKL
Upstream
0 3
Treatment
  • MG132
CREB3L2 (human) LQTLVMGkVSRtCKL K364-ub
CREB3L2 (mouse) LQTLVMGKVSRTCKL K364
CREB3L2 (rat) LQTLVMGKVSRTCKL K364
T368-p
VMGkVSRtCKLAGTQ
0 1
CREB3L2 (human) VMGkVSRtCKLAGTQ T368-p
CREB3L2 (mouse) VMGKVSRTCKLAGTQ T368
CREB3L2 (rat) VMGKVSRTCKLAGTQ T368
T482-p
HFIISNEtSLEKSVL
0 1
CREB3L2 (human) HFIISNEtSLEKSVL T482-p
CREB3L2 (mouse) HFLISNETSLEKSVL T483
CREB3L2 (rat) HFIISKETSLEKSVL T483
N504
VSAKLEGNETLKVVE
0 1
CREB3L2 (human) VSAKLEGNETLKVVE N504
CREB3L2 (mouse) VSSKLEGnETLKVVE N505-ng
CREB3L2 (rat) VSSKLEGNETLKVVE N505